We are live on ! Find out more
CNCE

Concert Pharmaceuticals, Inc.
CNCE

Delisted

CNCE was delisted on the 3rd of March, 2023.

Back to rankings

68 hedge funds and large institutions have $159M invested in Concert Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 6

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

71% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 14

54% more capital invested

Capital invested by funds: $103M → $159M (+$55.8M)

26% more funds holding

Funds holding: 54 → 68 (+14)

Holders
68
Holders Change
+14
Holders Change %
+25.93%
% of All Funds
1.81%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
20
Increased
24
Reduced
14
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$9.21M
2
Jennison Associates
Jennison Associates
New York
+$6.7M
3
SAM
Senzar Asset Management
New York
+$3.49M
4
SFM
Sphera Funds Management
Israel
+$3.14M
5
ACPU
Arrowgrass Capital Partners (US)
Delaware
+$2.06M

Top Sellers

Rank Fund Capital Flow
1
BIM
Bogle Investment Management
Massachusetts
-$1.52M
2
BA
BlackRock Advisors
Delaware
-$1.52M
3
TC
TFS Capital
Pennsylvania
-$1.24M
4
Citadel Advisors
Citadel Advisors
Florida
-$559K
5
BG
BlackRock Group
United Kingdom
-$283K
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
26
EverPoint Asset Management
Connecticut
$1.52M +$1.4M +100,700 New
Bank of America
27
Bank of America
North Carolina
$1.51M +$1.3M +93,060 +1,341%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$1.26M +$730K +52,287 +169%
EI
29
EAM Investors
California
$1.25M +$1.15M +82,434 New
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$1.18M – – –
Two Sigma Investments
31
Two Sigma Investments
New York
$1.06M +$348K +24,933 +55%
MIM
32
Monashee Investment Management
Massachusetts
$1.02M +$942K +67,500 New
CS
33
Credit Suisse
Switzerland
$965K +$545K +39,094 +159%
Tudor Investment Corp
34
Tudor Investment Corp
Connecticut
$773K +$712K +51,025 New
UOC
35
UBS O'Connor
Illinois
$757K +$698K +50,000 New
BCM
36
Bridgeway Capital Management
Texas
$659K – – –
TC
37
TFS Capital
Pennsylvania
$536K -$1.24M -89,104 -72%
PAM
38
Panagora Asset Management
Massachusetts
$495K +$456K +32,658 New
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$491K +$269K +19,283 +147%
Renaissance Technologies
40
Renaissance Technologies
New York
$453K +$417K +29,900 New
Two Sigma Advisers
41
Two Sigma Advisers
New York
$415K +$382K +27,400 New
Goldman Sachs
42
Goldman Sachs
New York
$381K +$78.3K +5,613 +29%
WMSA
43
Weiss Multi-Strategy Advisers
New York
$379K -$55.8K -4,000 -14%
Connor, Clark & Lunn Investment Management (CC&L)
44
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$379K +$160K +11,500 +85%
MCM
45
Moore Capital Management
New York
$379K +$349K +25,000 New
Wells Fargo
46
Wells Fargo
California
$365K -$137K -9,826 -29%
BG
47
BlackRock Group
United Kingdom
$353K -$283K -20,269 -47%
BCM
48
BlueCrest Capital Management
Jersey
$341K +$315K +22,542 New
Jane Street
49
Jane Street
New York
$308K +$284K +20,330 New
Northern Trust
50
Northern Trust
Illinois
$295K +$106K +7,594 +64%
1
2
3

CNCE Hedge Fund Activity: Q1 2015 in Review

68 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Concert Pharmaceuticals, Inc. (CNCE) for Q1 2015, worth a combined $159M — up 54% from $103M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new CNCE positions and 6 closed out — a net gain of 14 holders — while 24 added to existing stakes and 14 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $9.21M. The largest seller was Bogle Investment Management, exiting entirely with an estimated $1.52M sold.

  • 68 institutional investors held Concert Pharmaceuticals, Inc. (CNCE) as of Q1 2015, up from 54 in Q4 2014.
  • Funds reported $159M of Concert Pharmaceuticals, Inc. stock for Q1 2015, up 54% quarter-over-quarter.
  • 20 funds opened new Concert Pharmaceuticals, Inc. positions in Q1 2015 and 6 closed out, a net change of +14 holders.
  • The largest Concert Pharmaceuticals, Inc. buyer in Q1 2015 was RA Capital Management, an estimated $9.21M added.
  • The largest Concert Pharmaceuticals, Inc. seller in Q1 2015 was Bogle Investment Management, an estimated $1.52M sold.

Based on aggregated 13F filings for Q1 2015.